A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research

Journal of Clinical Epidemiology

Volumn 66, Issue 8, 2013, Pages 818-825

  Varadhan, Ravi ^a,b,d   Segal, Jodi B ^a,b   Boyd, Cynthia M ^a,b   Wu, Albert W ^a,b   Weiss, Carlos O ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Clinical trials; Comparative effectiveness research; Meta analysis; Observational studies; Prediction; Subgroup analysis

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL EVALUATION; CONCEPTUAL FRAMEWORK; DESCRIPTIVE RESEARCH; EXPLORATORY RESEARCH; HYPOTHESIS; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; PATIENT CARE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

COMPARATIVE EFFECTIVENESS RESEARCH; DATA INTERPRETATION, STATISTICAL; HUMANS; META-ANALYSIS AS TOPIC; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 84879843112     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.02.009     Document Type: Review

References (27)

1. A.E. Washington, and S.H. Lipstein The Patient-Centered Outcomes Research Institute - promoting better information, decisions, and health N Engl J Med 365 2011 e31
2. y Fernandez, E. Garcia, H. Nguyen, N. Duan, N.B. Gabler, and R.L. Kravitz Assessing heterogeneity of treatment effects: are authors misinterpreting their results? Health Serv Res 45 2010 283 301
3. S. Yusuf, J. Wittes, J. Probstfield, and H.A. Tyroler Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials JAMA 266 1991 93 98
4. P.M. Rothwell Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation Lancet 365 2005 176 186 (Pubitemid 40091809)
5. R. Wang, S.W. Lagakos, J.H. Ware, D.J. Hunter, and J.M. Drazen Statistics in medicine - reporting of subgroup analyses in clinical trials N Engl J Med 357 2007 2189 2194
6. X. Sun, M. Briel, S.D. Walter, and G.H. Guyatt Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses BMJ 340 2010 c117
7. J.N. Cohn, and G. Tongnoni A randomized trial of the angiotensin receptor blocker, valsartan, for congestive heart failure N Engl J Med 345 2001 1667 1675 (Pubitemid 33126822)
8. R. Temple How FDA currently makes decisions on clinical studies Clin Trials 2 2005 276 281 (Pubitemid 41306267)
9. BARI Investigators Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease N Engl J Med 335 1996 217 225
10. Agency for Healthcare Research and Quality. Health care: priority populations index page. Available at http://www.ahrq.gov/populations/. Accessed April 1, 2013.
11. K. Arnold Journal to encourage analysis by sex/ethnicity J Natl Cancer Inst 92 2000 1561
12. The Food and Drug Administration. Evaluation of sex differences in medical device clinical studies: draft guidance for industry and food and drug administration staff. December 2011.
13. T.R. Weizemann Sex-specific reporting of scientific research: a workshop summary 2012 Institute of Medicine, National Academies Press Washington, DC
14. W.J. Kostis, J.Q. Cheng, J.M. Dobrzynski, J. Cabrera, and J.B. Kostis Meta-analysis of statin effects in women versus men J Am Coll Cardiol 59 2012 572 582
15. D.M. Zulman, J.B. Sussman, X. Chen, C.T. Cigolle, C.S. Blaum, and R.A. Hayward Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials J Gen Intern Med 26 2011 783 790
16. C.S. Karapetis, S. Khambata-Ford, D.J. Jonker, C.J. O'Callaghan, D. Tu, and N.C. Tebbutt K-ras mutations and benefit from cetuximab in advanced colorectal cancer N Engl J Med 359 2008 1757 1765
17. D.P. Byar Assessing apparent treatment-covariate interactions in randomized clinical trials Stat Med 4 1985 255 263 (Pubitemid 15019385)
18. J.A.N. Dorresteijn, F.L.J. Visseren, P.M. Ridker, A.M.J. Wassink, N.P. Paynter, and E.W. Steyerberg Estimating treatment effects for individual patients based on the results of randomized clinical trials Br Med J 343 2011 d5888
19. T. Cai, L. Tian, P.H. Wong, and L.J. Wei Analysis of randomized comparative clinical trial data for personalized treatment selections Biostatistics 12 2011 270 282
20. D.M. Kent, P.M. Rothwell, J.P.A. Ioannidis, D.G. Altman, and R.A. Hayward Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal Trials 11 2010 85
21. T. Hastie, R. Tibshirani, and J. Friedman The elements of statistical learning. Springer series in statistics 2001 Springer New York
22. E.W. Steyerberg Clinical prediction models 2009 Springer New York/Heidelberg
23. L. Breiman Statistical modeling: the two cultures Stat Sci 16 2001 199 231 (Pubitemid 33636349)
24. T.J. VanderWeele, B. Mukherjee, and J. Chen Sensitivity analysis for interactions under unmeasured confounding Stat Med 2011 10.1002/sim.4354
25. D.P. Byar Why data bases should not replace randomized clinical trials Biometrics 36 1980 337 342
26. Sox HC, Helfand M, Grimshaw J, Dickersin K. PLoS medicine. Tovey D, Knottnerus JA, Tugwell P, editors. Comparative effectiveness research: challenges for medical journals. Am J Manag Care. 2010;16:e131-e133.
27. D.B. Rubin For objective causal inference, design trumps analysis Ann Appl Stat 2 2008 808 840